APA (7th ed.) Citation

J, H., W, F., T, S., AJ, G., G, A., K, W., . . . P, B. (2022). Half-Life Extended Nanobody-Based CD38-Specific Bispecific Killercell Engagers Induce Killing of Multiple Myeloma Cells. Frontiers in immunology, 13, 838406. https://doi.org/10.3389/fimmu.2022.838406

Chicago Style (17th ed.) Citation

J, Hambach, Fumey W, Stähler T, Gebhardt AJ, Adam G, Weisel K, Koch-Nolte F, and Bannas P. "Half-Life Extended Nanobody-Based CD38-Specific Bispecific Killercell Engagers Induce Killing of Multiple Myeloma Cells." Frontiers in Immunology 13 (2022): 838406. https://doi.org/10.3389/fimmu.2022.838406.

MLA (9th ed.) Citation

J, Hambach, et al. "Half-Life Extended Nanobody-Based CD38-Specific Bispecific Killercell Engagers Induce Killing of Multiple Myeloma Cells." Frontiers in Immunology, vol. 13, 2022, p. 838406, https://doi.org/10.3389/fimmu.2022.838406.